Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 25Active not recruiting 5Terminated 4Recruiting 4Unknown 3Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Small Cell Lung Carcinoma 4Ovarian Neoplasms 3Fallopian Tube Neoplasms 3Neuroblastoma 2SCLC, Extensive Stage 1Neoplasms 1Ganglioneuroblastoma 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Cyclophosphamide 3naxitamab 2fludarabine phosphate 2fludarabine 2dinutuximab 2Topotecan 2Granulocyte-Macrophage Colony-Stimulating Factor 2Colony-Stimulating Factors 2sargramostim 1iberdomide 1eliglustat 1Vorinostat 1Thiotepa 1Tacrolimus 1Mycophenolic Acid 1Methotrexate 1Melphalan 1Magnetic Resonance Spectroscopy 1Isotretinoin 1Cyclosporine 1Busulfan 1Biopsy 1Antilymphocyte Serum 13-Iodobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Neuroblastoma × Topotecan × Clear all
NCT07437963 2026-04-15

Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse

National Cancer Institute (NCI)

Phase 1/2 Not yet recruiting
76 enrolled
CNS

Neuroblastoma, Ganglioneuroblastoma

NCT05303727 2022-07-01

Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Not yet recruiting
64 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡